TY -的T1所需水平的鼻持续正压通气治疗阻塞性睡眠呼吸暂停期间摩根富林明-欧洲呼吸杂志》乔和J SP - 1776 LP - 1781欧元六世- 7 - 10盟系列F AU -马克,我非盟——Cormier, Y AU - La Forge J Y1 - 1994/10/01 UR - //www.qdcxjkg.com/content/7/10/1776.abstract N2 -改善阻塞性睡眠呼吸障碍的严重程度在鼻持续正压通气(NCPAP)治疗可以减少占所需NCPAP水平随着时间的推移。本研究的目的是为了预期量化的变化需要NCPAP水平随着时间的推移使用睡眠apnoea-hypopnoea综合症(sah)。四十睡眠apnoea-hypopnoea患者评估之前和期间的NCPAP治疗。有效NCPAP级别定义为积极的压力级别,废除apnoeic和hypopnoeic事件和打鼾睡眠阶段和睡眠的位置。这种压力级别确定后2周内基线诊断睡眠研究。睡眠研究和NCPAP NCPAP滴定法进行2 (n = 40)后,8 (n = 40), 20 (n = 24)个月NCPAP治疗。初始有效为9.6 + / - 0.4 cmH2O NCPAP水平。它逐渐下降到8.8 + / - 0.4,7.9 + / - 0.4和7.7 + / - 0.5 2,8和20个月,分别;之间的区别是重要的前三个NCPAP晚上。有一个贫穷的变化之间的关系有效NCPAP和体重的变化在不同的访问记录。 There was a weak negative relationship between the changes in NCPAP and the previous NCPAP level. In 13 patients, the apnoea-hypopnoea index (AHI) remained > 10 n.h-1 at the first NCPAP trial because the effective NCPAP level was not tolerated. Despite a suboptimal NCPAP level, their sleep architecture improved, and they all reported a subjective improvement in diurnal hypersomnolence.(ABSTRACT TRUNCATED AT 250 WORDS) ER -